Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dolby Laboratories, Inc. Director's Dealing 2020

Feb 6, 2020

30828_dirs_2020-02-05_732e311c-9369-4800-8ce1-12e9f8f77450.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2020-02-03

Reporting Person: Forshay Steven E (SVP, Advanced Technology Group)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-03 Class A Common Stock M 46000 $33.15 Acquired 107317.826 Direct
2020-02-03 Class A Common Stock S 46000 $69.80 Disposed 61317.826 Direct
2020-02-03 Class A Common Stock M 4000 $45.50 Acquired 65317.826 Direct
2020-02-03 Class A Common Stock S 4000 $69.80 Disposed 61317.826 Direct
2020-02-04 Class A Common Stock M 15000 $45.50 Acquired 76317.826 Direct
2020-02-04 Class A Common Stock S 15000 $70.8704 Disposed 61317.826 Direct
2020-02-04 Class A Common Stock M 30833 $45.50 Acquired 92150.826 Direct
2020-02-04 Class A Common Stock S 30833 $71.0033 Disposed 61317.826 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-03 Employee Stock Option (right to buy) $33.15 M 46000 Disposed 2025-12-15 Class A Common Stock (46000) Direct
2020-02-03 Employee Stock Option (right to buy) $45.50 M 4000 Disposed 2023-12-15 Class A Common Stock (4000) Direct
2020-02-04 Employee Stock Option (right to buy) $45.50 M 15000 Disposed 2023-12-15 Class A Common Stock (15000) Direct
2020-02-04 Employee Stock Option (right to buy) $45.50 M 30833 Disposed 2026-12-15 Class A Common Stock (30833) Direct

Footnotes

F1: Shares held following the reported transactions include 9,250 restricted stock units, which are subject to forfeiture until they vest.

F2: The shares were sold in multiple transactions at prices ranging from $70.48 to $71.00, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: The shares were sold in multiple transactions at prices ranging from $71.00 to $71.03, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: This option was granted for a total of 46,000 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2015, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.

F5: This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 19,000 shares.

F6: This option was granted for a total of 40,000 shares of Class A Common. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter.